TotalMarketCap

Q32 Bio

QTTBNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$265.126 M

$8.86 -1.23%

Close of 6 Nov 2026

As of 6 Nov 2026, Q32 Bio (QTTB) has a market capitalization of $265.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$53.7M

#2689 by revenue

Earnings

$29.8M

#1738 by earnings

Shares outstanding

29,923,882

Latest filing cover page

P/E ratio

8.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #226Arcturus TherapeuticsARCT$266.9M
  2. #227Cypherpunk TechnologiesCYPH$265.6M
  3. #228Q32 BioQTTB$265.1M
  4. #229ARS PharmaceuticalsSPRY$263.0M
  5. #230EvommuneEVMN$262.8M

What if Q32 Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$943,623.35

Per share 106,504× higher

Bitcoin $1.53T

$51,057.82

Per share 5,763× higher

Apple $5.02T

$167,618.05

Per share 18,919× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Q32 Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.